Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02642471
Other study ID # 2015-FXY-073
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 2015
Est. completion date December 2022

Study information

Verified date July 2020
Source Sun Yat-sen University
Contact Jihong Liu, Ph. D
Phone 86-20-87343102
Email liujih@mail.sysu.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The diagnostic value of sentinel lymph node biopsy in early-stage cervical cancer has been well studied. However, there were no randomized controlled study on comparing the long-term outcomes of sentinel lymph node biopsy and conventional procedure. The investigators perform a phase III, randomized controlled trial to determine whether pelvic lymphadenectomy can be replaced by sentinel lymph node biopsy in surgical treatment for patients with early-stage cervical cancer.


Description:

This study comprises two parts: PHENIX-I: To compare the outcomes of managements with and without pelvic lymphadenectomy for patients with negative sentinel lymph node; PHENIX-II: To compare the outcomes of managements with and without pelvic lymphadenectomy for patients with positive sentinel lymph node. Patients with newly diagnosed International Federation of Gynecology and Obstetrics (FIGO) stage IA1 (lymphovascular space involvement), IA2, IB1, and IB2 cervical cancer are eligible for our study. The tumor diameter should be less than 3cm. Sentinel lymph node biopsy will be performed at the beginning of operations. After pathological examination of frozen section, patients will be assigned to PHENIX-I or PHENIX-II study according to their status of sentinel nodes. In both parts of this trail, patients have equal chance to be randomly assigned to experimental arms (radical hysterectomy only) and reference arms (radical hysterectomy and pelvic lymphadenectomy).Adjuvant treatments will be planned according to postoperative pathological factors. The primary objective is disease-free survival at 3 years for PHENIX-I and 2 years for PHENIX-II. The secondary end points are overall survival, long-term outcome of sentinel lymph node biopsy and the quality of life.


Recruitment information / eligibility

Status Recruiting
Enrollment 1080
Est. completion date December 2022
Est. primary completion date December 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Patients with newly histologically confirmed cervical carcinoma

- Histopathology squamous carcinoma, adenocarcinoma or adeno-squamous carcinoma

- Original clinical stage must be FIGO (2018) stage IA1 (lymphovascular space involvement), IA2, IB1, and IB2

- No suspected node should be found on imaging examination (RESIST 1.1)

- Age between 18-65

- Patients must give signed informed consent

- P.S status: 0-1

- Estimated survival time > 3 months

- Tumor diameter = 3 cm

Exclusion Criteria:

- The presence of uncontrolled life-threatening illness

- Receiving other ways of anti-cancer therapy

- Investigator consider the patients can't finish the whole study

- With normal liver function test (ALT?AST>2.5×ULN)

- With normal renal function test (Creatinine>1.5×ULN)

- WBC<4,000/mm3 or PLT<100,000/mm

- The whole cervix has been occupied by tumor and there is no normal surface left for tracer injection

- History of severe heart disease or deep venous thrombosis; 4) Presence or history of other malignant disease

- Gestation or perinatal period

- Intention to fertility preservation.

Study Design


Intervention

Procedure:
no systematic pelvic lymphadenectomy
systematic pelvic lymphadenectomy is omitted in surgical treatment

Locations

Country Name City State
China Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Sun Yat-sen University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Disease free survival in PHENIX-I 3 years
Primary Disease free survival in PHENIX-II 2 years
Secondary Surgical morbidity 3 years
Secondary Rate of retroperitoneal node recurrence 3 years
Secondary Overall survival 5 years
Secondary Patients' quality of life 5 years
Secondary Performance of SLN detection 3 years
Secondary Diagnostic accuracy of frozen section examination 3 years
Secondary Anatomic distribution of SLNs 3 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT06238557 - Prospective Evaluation of Psychological Consequences and Impact on Long-term Quality of Life
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT05472935 - Asynchronous Mindfulness Based Stress Reduction to Reduce Burnout in Licensed Clinical Social Workers N/A
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04281953 - Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
Recruiting NCT05546931 - Mobile Health Program for Rural Hypertension N/A
Active, not recruiting NCT04746664 - Effects of Nutrition Counselling on Old Age People's Nutritional Status and Quality of Life in Bahir Dar City, North West Ethiopia N/A
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Recruiting NCT04142827 - The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX) N/A
Active, not recruiting NCT05903638 - A Pilot RCT: the Impact of a Virtual MBSR Course on Women With Primary Infertility N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Completed NCT06216015 - Exercise Training and Kidney Transplantation N/A
Completed NCT03813420 - Sleep Quality of Physiotherapy Students Quality of Life and Physical Activity Level N/A
Recruiting NCT05550545 - Infant RSV Infections and Health-related Quality of Life of Families
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Recruiting NCT05233020 - Robotic Versus Hybrid Assisted Ventral Hernia Repair N/A
Terminated NCT03304184 - The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life Phase 3
Completed NCT05063305 - Probiotics, Immunity, Stress, and QofL N/A
Recruiting NCT05380856 - Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction N/A